Quick answer
Peptide Therapy describes a category of consultation-based protocols planned around your labs, history, and goals. Selection, dosing, and cadence are physician-guided. It is not a disease treatment and is not appropriate for every individual.
What peptides are, briefly
Peptides are short chains of amino acids that signal in specific biological pathways. Different peptides are referenced for different goals — recovery support, performance, sleep, or longevity-focused planning.
What a consultation actually covers
A peptide consultation reviews your history, labs, current medications, and goals. If a peptide plan is appropriate, your provider will outline selection, dosing, cadence, and expectations.
Where it makes sense, peptide plans are sequenced with IV Therapy, EBO3, HBOT, or regenerative biologics as part of a broader strategy.
Compliance and screening
Honest intake is critical. Peptide planning is not a self-service menu — it is a screened, physician-guided process designed to fit your individual context.
Frequently asked
- Are peptides FDA-approved?
- We do not make FDA approval claims. Peptide protocols are physician-guided and personalized after screening.
- Is this a substitute for medical treatment?
- No. Peptide planning is wellness-focused and is not intended to diagnose or treat disease.
- Can I combine peptides with EBO3 or HBOT?
- When appropriate, yes — your provider will sequence the plan based on your goals.
Related services
Ready to talk with our team?
Book a complimentary consultation at our Rancho Palos Verdes or West Palm Beach clinic.
Request a ConsultationRelated reading
More from the EBO2 Therapy and Wellness library.
How Physician-Guided Longevity Care Works
Learn how physician guided longevity care works, from private screening and targeted testing to personalized, provider-guided wellness protocols today.
Read
How EBO2 Therapy Sessions Work in Practice
Learn how ebo2 therapy sessions work with private screening, monitored care, recovery guidance, and personalized planning at concierge wellness clinics.
ReadIV Therapy: A Personalized Wellness Approach
Explore physician-supervised IV therapy, from personalized nutrient selection and screening to recovery, cellular wellness, and concierge care planning.
ReadFDA approvals for GLP-1 products such as WEGOVY are specific to a particular product, route, dose, and indication and do NOT transfer to compounded semaglutide, unapproved GLP-1 formulations, or investigational peptide stacks (e.g. BPC-157, MOTS-c, TB-500). FDA has flagged dosing errors with compounded semaglutide and safety risks with several bulk peptide substances. Programs at EBO2 remain physician-supervised.
- WEGOVY (semaglutide) — FDA prescribing label
DailyMed (U.S. National Library of Medicine)
Current FDA-approved prescribing information for WEGOVY, defining approved indication, dosing, route, and safety information. Approval is product/route/indication-specific.
- FDA alerts providers, compounders, and patients to dosing errors with compounded semaglutide
U.S. Food & Drug Administration
FDA safety alert on dosing errors associated with compounded semaglutide. Regulatory/safety context only; does not endorse compounded products.
- FDA intends to take action against non-FDA-approved GLP-1 drugs
U.S. Food & Drug Administration
FDA statement on planned enforcement against non-FDA-approved GLP-1 products. Regulatory context; not a recommendation for any specific program.
- FDA — Certain Bulk Drug Substances Used to Compound Drug Products May Present Significant Safety Risks
U.S. Food & Drug Administration
FDA safety-risk framing for bulk drug substances used in compounding — the category that covers BPC-157, MOTS-c, TB-500, and related investigational peptides. Risk/regulatory context only.
- FDA — Unapproved Drugs enforcement policy overview
U.S. Food & Drug Administration
FDA overview of how the agency treats drugs that lack FDA approval, providing regulatory context for compounded and unapproved products.
References describe general evidence, safety, or regulatory context. They do not establish an individual benefit for any specific person, and they do not validate EBO2's proprietary clinic protocols.
Medical Disclaimer: This article is educational and is not a substitute for medical advice, diagnosis, or treatment. Programs are physician-guided, consultation-based, and personalized after screening. Results vary.
